Your browser doesn't support javascript.
loading
Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR-Mutant NSCLC.
Le, Xiuning; Puri, Sonam; Negrao, Marcelo V; Nilsson, Monique B; Robichaux, Jacqulyne; Boyle, Theresa; Hicks, J Kevin; Lovinger, Katherine L; Roarty, Emily; Rinsurongkawong, Waree; Tang, Ming; Sun, Huiying; Elamin, Yasir; Lacerda, Lara C; Lewis, Jeff; Roth, Jack A; Swisher, Stephen G; Lee, J Jack; William, William N; Glisson, Bonnie S; Zhang, Jianjun; Papadimitrakopoulou, Vassiliki A; Gray, Jhanelle E; Heymach, John V.
Afiliação
  • Le X; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Puri S; Department of Thoracic Oncology, the H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Negrao MV; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Nilsson MB; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Robichaux J; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Boyle T; Department of Molecular Pathology, the H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Hicks JK; Department of Molecular Pathology, the H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Lovinger KL; Department of Molecular Pathology, the H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Roarty E; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Rinsurongkawong W; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tang M; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sun H; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Elamin Y; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lacerda LC; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lewis J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Roth JA; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Swisher SG; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • William WN; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Glisson BS; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhang J; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Papadimitrakopoulou VA; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gray JE; Department of Thoracic Oncology, the H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. jheymach@mdanderson.org jhanelle.gray@moffitt.org.
  • Heymach JV; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. jheymach@mdanderson.org jhanelle.gray@moffitt.org.
Clin Cancer Res ; 24(24): 6195-6203, 2018 12 15.
Article em En | MEDLINE | ID: mdl-30228210

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acrilamidas / Carcinoma Pulmonar de Células não Pequenas / Resistencia a Medicamentos Antineoplásicos / Compostos de Anilina / Neoplasias Pulmonares / Mutação / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acrilamidas / Carcinoma Pulmonar de Células não Pequenas / Resistencia a Medicamentos Antineoplásicos / Compostos de Anilina / Neoplasias Pulmonares / Mutação / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos